March 2015 FDA Recall Drug by Safecor Health, Llc
D-0661-2016 - Defective Container
This Class II drug recall was voluntarily initiated by Safecor Health, Llc on March 2, 2015 for the product Drug. The FDA reported the reason for recall as defective container. The product was distributed in NJ and the recall is currently terminated.
Recall Number: D-0661-2016
Defective Container: Confirmed customer complaints of leaking bottles.
03-02-2015
02-17-2016
3,532 amber bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Safecor Health, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
NJ
02-25-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Haloperidol Oral Solution, USP (Concentrate) 2 mg/mL 15 mL amber bottle, Rx Only, Manufactured by Silarx Pharmaceuticals Inc. Carmel, NY 10512, Packaged by Safecor Health, Woburn, MA 01801, NDC 54838-0501-40.
Batch or Lot Expiration Information
Lot# 846881; Exp 01/16